PROM Detail

Home PROM Detail
Quality of Life in Adult Cancer Survivors
  • Basic Information
  • Detailed Information
  • Domains
  • Psychometrics

Basic Information

Abbreviated name
QLACS
Full name
Quality of Life in Adult Cancer Survivors
Items ?
The number of questions in the survey
47
Short description
The QLACS is a measure specifically focusing on the quality of life of long-term cancer survivors . It is based on the multidimensional cancer-related quality of life model, which takes into account both functioning and patient satisfaction with functioning. Long-term cancer survivorship has been defined as the period exceeding diagnosis for at least 5 years. It has been used in a large UK national follow up study of cancer survivors :http://www.ncbi.nlm.nih.gov/pubmed/22048028
PCCC or QoL? ?
This compendium contains patient-reported measures that are either designed to specifically measure aspects of Person Centred Co-Ordinated Care (P3C), or alternatively tools that are designed to measure some aspect of Quality of Life (QoL) or Health Related Quality of Life (hrQoL). All the measures in this compendium have been broadly categorised into one of those two concepts.
Quality of Life
Main Domains Measured ?
This is the key domains that the measure is targeting.
Generic domains include those that are not necessarily attributable to cancer
Type of measure ?
The measures in this compendium can take a variety of forms. Generally, they will be either Patient Reported Outcome Measure (PROM) or Patient Reported Experience Measure (PREM). However, we have also included a few measures that are completed by proxy-individual (PROXY), which are useful in instances where the respondent cannot answer directly (e.g. dementia or end of life). Sometimes, these measures can even be a composite of these types, and target both experiences and outcomes – we have labelled these measures “PROEMs”.
PROM
Respondent ?
The person that fills in the questionnaire - e.g. patient, Health Care Professional, or proxy (normally a carer or family member)
Patients

Detailed Information

Year developed ?
The year in which the measure was first published.
2006
Country developed in ?
The main country[s] in which the measure was first developed.
US
Original publication ?
The publication in which the measure was originally published.
Search Citations of Original Reference
http://www.ncbi.nlm.nih.gov/pubmed/17140438
Target condition ?
The measures can be either generic or disease specific (e.g. Diabetes, Heart Failure)
Cancer
Main context tested in ?
The main context in which the measure has been developed and used (E.g. Hopital, General Practice etc).
Breast Cancer survivor follow-up
Main countries used in ?
The main countries in which the measure has been developed and used.
US
Target age ?
e.g. Adults, Children, Elderly
Adults
Main uses of measure ?
The context in which the measure is most often used – e.g. clinical trials; national surveys.
Designed to assess HRQoL among long-term cancer survivors.
Used in UK? ?
Whether the instrument has been tested and validated within a UK healthcare context.
Yes
Impact ?
A crude indication of the impact of the measure on academia. This is the number of times the original publication has been cited on PubMed, divided/normalised to the years since publication.
1.4
Language
English

Domains

Domain description
Generic domains include those that are not necessarily attributable to cancer

Psychometrics

Brief description ?
A brief description of the initially reported psychometric properties of the measure.
Construct, convergent/divergent and retrospective validity, responsiveness to change, and reliability (both internal consistency and temporal stability) have been tested in two different studies. Internal consistency: A comprised between 0.72 and 0.95 in each factor; temporal stability (after 2 weeks): r>0.70 in each factor.